Effect of prostaglandin E 1  and E 2  on the vascular responsiveness to adrenaline, noradrenaline, angiotensin and vasopressin.
D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D004837:Epinephrine / Q000037:antagonists & inhibitors*; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D010208:Papaverine / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D014667:Vasopressins / Q000037:antagonists & inhibitors*
D011453:Prostaglandins; D014667:Vasopressins; D000804:Angiotensin II; D012110:Reserpine; D010208:Papaverine; D009638:Norepinephrine; D004837:Epinephrine